Clinical Trial Update: A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating consumer self-selection and use of gabapentin for occasional sleeplessness in an OTC setting; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Insomnia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Transient Insomnia | Phase 3 | Status: COMPLETED